These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 15302115

  • 1. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task.
    Giorgi M, Modica A, Pompili A, Pacitti C, Gasbarri A.
    Behav Brain Res; 2004 Sep 23; 154(1):99-106. PubMed ID: 15302115
    [Abstract] [Full Text] [Related]

  • 2. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):107-12. PubMed ID: 17207788
    [Abstract] [Full Text] [Related]

  • 3. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
    Marko D, Romanakis K, Zankl H, Fürstenberger G, Steinbauer B, Eisenbrand G.
    Cell Biochem Biophys; 1998 Mar 08; 28(2-3):75-101. PubMed ID: 9515161
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E, Lee R, Near R, Weintraub L, Wolda S, Lerner A.
    Clin Cancer Res; 2002 Feb 08; 8(2):589-95. PubMed ID: 11839681
    [Abstract] [Full Text] [Related]

  • 5. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B, Kelly J, Vemavarapu L, Thompson WJ, Strada SJ.
    Biochem Pharmacol; 2004 Aug 01; 68(3):479-91. PubMed ID: 15242814
    [Abstract] [Full Text] [Related]

  • 6. Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.
    Levallet G, Levallet J, Bouraïma-Lelong H, Bonnamy PJ.
    Biol Reprod; 2007 May 01; 76(5):794-803. PubMed ID: 17215491
    [Abstract] [Full Text] [Related]

  • 7. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM, Xie QM, Tang HF, Sun JG, Deng JF, Chen JQ, Yang SY.
    Eur J Pharmacol; 2006 Oct 10; 547(1-3):125-35. PubMed ID: 16956605
    [Abstract] [Full Text] [Related]

  • 8. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
    Cheung YF, Kan Z, Garrett-Engele P, Gall I, Murdoch H, Baillie GS, Camargo LM, Johnson JM, Houslay MD, Castle JC.
    J Pharmacol Exp Ther; 2007 Aug 10; 322(2):600-9. PubMed ID: 17519386
    [Abstract] [Full Text] [Related]

  • 9. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
    Ahlström M, Pekkinen M, Huttunen M, Lamberg-Allardt C.
    Biochem Pharmacol; 2005 Jan 15; 69(2):267-75. PubMed ID: 15627479
    [Abstract] [Full Text] [Related]

  • 10. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
    Makhay MM, Houslay MD, O'Donnell JM.
    Psychopharmacology (Berl); 2001 Nov 15; 158(3):297-304. PubMed ID: 11713620
    [Abstract] [Full Text] [Related]

  • 11. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
    Itoh T, Tokumura M, Abe K.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):135-42. PubMed ID: 15363987
    [Abstract] [Full Text] [Related]

  • 12. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
    Nagakura A, Niimura M, Takeo S.
    Br J Pharmacol; 2002 Apr 13; 135(7):1783-93. PubMed ID: 11934820
    [Abstract] [Full Text] [Related]

  • 13. Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects.
    Landells LJ, Szilagy CM, Jones NA, Banner KH, Allen JM, Doherty A, O'Connor BJ, Spina D, Page CP.
    Br J Pharmacol; 2001 Jul 13; 133(5):722-9. PubMed ID: 11429397
    [Abstract] [Full Text] [Related]

  • 14. Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement.
    Hosseini-Sharifabad A, Ghahremani MH, Sabzevari O, Naghdi N, Abdollahi M, Beyer C, Bollen E, Prickaerts J, Roghani A, Sharifzadeh M.
    Pharmacol Biochem Behav; 2012 May 13; 101(3):311-9. PubMed ID: 22306745
    [Abstract] [Full Text] [Related]

  • 15. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M, Dubois M, Grynberg A, Lagarde M, Prigent AF.
    J Mol Cell Cardiol; 1996 Oct 13; 28(10):2151-61. PubMed ID: 8930810
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L, Thompson WJ, Potter DE.
    Invest Ophthalmol Vis Sci; 1999 Jul 13; 40(8):1745-52. PubMed ID: 10393044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.